Omega Diagnostics (#ODX) – selected a preferred bidder for CD4 business, £2m overdraft facility extended by 3 months
- 2022-07-04 07:57:59
Oh dear. Oh dear. The chaps running Omega Diagnostics (ODX) really are incompetent poltroons. I wonder how my favourite Saltire waving troll Craig Inglis - who first inspired me to start investigating this POS - feels about the latest dire news: The UK Health Security Agency rejecting an application for approval of the professional-use VISITECT® COVID-19 Antigen test. Ooops.
Yesterday afternoon at 3.40 PM AIM sewer dog Omega Diagnostics (ODX) stunned the market with news that shareholders had committed financial hara kiri by voting down GM Resolutions to allow the proposed £5.48 million placing and open offer. That was madness, what followed was utter madness.
As I explained in the free to access podcast yesterday, shareholders in Omega Diagnostics (ODX) should be blaming the company and its advisers FinnCap and Paul “Queenie” McManus of Walbrook PR for their losses. I have written to the Oxymorons at AIM Regulation asking for an investigation into CEO Jag Grewal, CFO Chris Lea, Geoff Nash and Alice Lane at FinnCap and into Queenie himself.